Ernst Lengyel to Molecular Targeted Therapy
This is a "connection" page, showing publications Ernst Lengyel has written about Molecular Targeted Therapy.
Connection Strength
0.403
-
Molecular changes driving low-grade serous ovarian cancer and implications for treatment. Int J Gynecol Cancer. 2024 Oct; 34(10):1630-1638.
Score: 0.187
-
Molecular changes driving low-grade serous ovarian cancer and implications for treatment. Int J Gynecol Cancer. 2024 10 07; 34(10):1630-1638.
Score: 0.184
-
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer. Mol Cancer Res. 2019 04; 17(4):870-881.
Score: 0.031